These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 31473026)
21. A common missense variant of LILRB5 is associated with statin intolerance and myalgia. K Siddiqui M; Maroteau C; Veluchamy A; Tornio A; Tavendale R; Carr F; Abelega NU; Carr D; Bloch K; Hallberg P; Yue QY; Pearson ER; Colhoun HM; Morris AD; Dow E; George J; Pirmohamed M; Ridker PM; Doney ASF; Alfirevic A; Wadelius M; Maitland-van der Zee AH; Chasman DI; Palmer CNA; Eur Heart J; 2017 Dec; 38(48):3569-3575. PubMed ID: 29020356 [TBL] [Abstract][Full Text] [Related]
22. Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia? Glueck CJ; Rawal B; Khan NA; Yeramaneni S; Goldenberg N; Wang P Metabolism; 2009 Feb; 58(2):233-8. PubMed ID: 19154957 [TBL] [Abstract][Full Text] [Related]
29. Symptomatic myositis-myalgia in hypercholesterolemic statin-treated patients with concurrent vitamin D deficiency leading to statin intolerance may reflect a reversible interaction between vitamin D deficiency and statins on skeletal muscle. Glueck CJ; Abuchaibe C; Wang P Med Hypotheses; 2011 Oct; 77(4):658-61. PubMed ID: 21802861 [TBL] [Abstract][Full Text] [Related]
31. The Challenge: Finding the Most Appropriate Statin and Dose for Each Patient. Lillo JL J Fam Pract; 2021 Jul; 70(6S):S53-S58. PubMed ID: 34432625 [TBL] [Abstract][Full Text] [Related]
32. Managing statin-induced muscle toxicity in a lipid clinic. Blaier O; Lishner M; Elis A J Clin Pharm Ther; 2011 Jun; 36(3):336-41. PubMed ID: 21414023 [TBL] [Abstract][Full Text] [Related]
33. Introducing the 'Drucebo' effect in statin therapy: a systematic review of studies comparing reported rates of statin-associated muscle symptoms, under blinded and open-label conditions. Penson PE; Mancini GBJ; Toth PP; Martin SS; Watts GF; Sahebkar A; Mikhailidis DP; Banach M; J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1023-1033. PubMed ID: 30311434 [TBL] [Abstract][Full Text] [Related]
34. Statin-Associated Side Effects. Thompson PD; Panza G; Zaleski A; Taylor B J Am Coll Cardiol; 2016 May; 67(20):2395-2410. PubMed ID: 27199064 [TBL] [Abstract][Full Text] [Related]
35. N-of-1 (single-patient) trials for statin-related myalgia. Joy TR; Monjed A; Zou GY; Hegele RA; McDonald CG; Mahon JL Ann Intern Med; 2014 Mar; 160(5):301-10. PubMed ID: 24737272 [TBL] [Abstract][Full Text] [Related]
36. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association. Newman CB; Preiss D; Tobert JA; Jacobson TA; Page RL; Goldstein LB; Chin C; Tannock LR; Miller M; Raghuveer G; Duell PB; Brinton EA; Pollak A; Braun LT; Welty FK; Arterioscler Thromb Vasc Biol; 2019 Feb; 39(2):e38-e81. PubMed ID: 30580575 [TBL] [Abstract][Full Text] [Related]
37. Statins and myotoxicity: a therapeutic limitation. Tiwari A; Bansal V; Chugh A; Mookhtiar K Expert Opin Drug Saf; 2006 Sep; 5(5):651-66. PubMed ID: 16907655 [TBL] [Abstract][Full Text] [Related]
38. [How do you manage muscle pain?"]. Klein F MMW Fortschr Med; 2016 Feb; 158(3):19. PubMed ID: 27119671 [No Abstract] [Full Text] [Related]
39. Changes in muscle strength in patients with statin myalgia. Panza GA; Taylor BA; Roman W; Thompson PD Am J Cardiol; 2014 Oct; 114(8):1215-6. PubMed ID: 25171803 [TBL] [Abstract][Full Text] [Related]
40. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis. Harper CR; Jacobson TA Curr Opin Lipidol; 2007 Aug; 18(4):401-8. PubMed ID: 17620856 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]